KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Other Non-Current Liabilities (2016 - 2025)

Amgen (AMGN) has 17 years of Other Non-Current Liabilities data on record, last reported at $2.5 billion in Q2 2025.

  • For Q2 2025, Other Non-Current Liabilities rose 2246.73% year-over-year to $2.5 billion; the TTM value through Jun 2025 reached $2.5 billion, up 2246.73%, while the annual FY2024 figure was $2.3 billion, 49.81% down from the prior year.
  • Other Non-Current Liabilities reached $2.5 billion in Q2 2025 per AMGN's latest filing, up from $2.3 billion in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $7.0 billion in Q1 2021 and bottomed at $96.0 million in Q1 2024.
  • Average Other Non-Current Liabilities over 5 years is $2.3 billion, with a median of $2.2 billion recorded in 2021.
  • Peak YoY movement for Other Non-Current Liabilities: tumbled 96.59% in 2023, then soared 2246.73% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $342.0 million in 2021, then decreased by 21.05% to $270.0 million in 2022, then soared by 1633.33% to $4.7 billion in 2023, then plummeted by 49.81% to $2.3 billion in 2024, then rose by 6.9% to $2.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $2.5 billion in Q2 2025, $2.3 billion in Q4 2024, and $2.3 billion in Q3 2024.